ConductScience.org, home

Paper668802

Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes.

Van Snick JL and 4 others. Eur J Immunol, 1978. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes. Papers, record 668802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/668802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes.
PubMed
Journal
Eur J Immunol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
2.53
iCite
Revised in PubMed
2005-11-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Snick JLJ L
2Van Roost EE
3Markowetz BB
4Cambiaso CLC L
5Masson PLP L

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MacrophagesMajor topic
PhagocytosisMajor topic
Rheumatoid FactorMajor topic
Animals
Antigen-Antibody Complex
Arthritis, Rheumatoid
Complement System Proteins
Female
Humans
Immunoglobulin G
Mice
Mice, Inbred Strains
Monocytes

Source PubMed

Download CSV of topics

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42136488Rheumatoid Arthritis: A Comprehensive Review of Etiology, Pathophysiology, and Innovative Therapeutic Advancements.Curr Pharm Des2026https://conductscience.org/library/papers/42136488PubMed
40094988Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis.J Clin Med2025https://conductscience.org/library/papers/40094988PubMed
39835117Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.Front Immunol2024https://conductscience.org/library/papers/39835117PubMed
38487524Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.Front Immunol2024https://conductscience.org/library/papers/38487524PubMed
37956528Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19.J Autoimmun2024https://conductscience.org/library/papers/37956528PubMed
33546243Rheumatoid Factor: A Novel Determiner in Cancer History.Cancers (Basel)2021https://conductscience.org/library/papers/33546243PubMed
33445768From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.Int J Mol Sci2021https://conductscience.org/library/papers/33445768PubMed
33327600Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics.Biomolecules2020https://conductscience.org/library/papers/33327600PubMed
31845355Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology.Immunol Rev2020https://conductscience.org/library/papers/31845355PubMed
30858306Cardiac phenotype in mouse models of systemic autoimmunity.Dis Model Mech2019https://conductscience.org/library/papers/30858306PubMed
25962087Cross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity.MAbs2015https://conductscience.org/library/papers/25962087PubMed
25566247Neutralization-Enhancing RF Antibodies for HIV Vaccines.Front Immunol2014https://conductscience.org/library/papers/25566247PubMed
23351360A rheumatoid factor paradox: inhibition of rituximab effector function.Arthritis Res Ther2013https://conductscience.org/library/papers/23351360PubMed
19926660Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.QJM2010https://conductscience.org/library/papers/19926660PubMed
9151704Role of repetitive antigen patterns for induction of antibodies against antibodies.J Exp Med1997https://conductscience.org/library/papers/9151704PubMed
8793270Rheumatoid factor in patients with systemic lupus erythematosus.Clin Rheumatol1996https://conductscience.org/library/papers/8793270PubMed
7809146Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7809146PubMed
7327699Rheumatoid factor and monosodium urate crystal-neutrophil interactions in gouty inflammation.Inflammation1981https://conductscience.org/library/papers/7327699PubMed
6976413Monoclonal anti-IgG autoantibodies derived from lipopolysaccharide-activated spleen cells of 129/Sv mice.J Exp Med1982https://conductscience.org/library/papers/6976413PubMed
6974064In vivo generation and clearance of soluble immune complexes containing IgM antibodies in normal and decomplemented rabbits.Clin Exp Immunol1981https://conductscience.org/library/papers/6974064PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/668802

GET https://conductscience.org/api/papers/v1/668802/cited_by?page=2